Filing Details

Accession Number:
0001144204-13-002711
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-01-16 21:30:41
Reporting Period:
2010-12-13
Filing Date:
2013-01-16
Accepted Time:
2013-01-16 21:30:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1424812 Amarantus Bioscience Inc. AMBS Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1567140 Lewis Robert Harris 402 Sequoyah Road
Oakland CA 94605-4538
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-07-26 7,000 $0.02 1,344,332 No 4 P Direct
Common Stock Acquisiton 2013-01-14 50,000 $0.10 1,394 No 5 P Direct
Convertible Series B Preferred Stock Acquisiton 2012-07-15 31,250 $0.00 31,250 No 4 A Direct
Convertible Series B Preferred Stock Acquisiton 2012-11-04 100,000 $0.00 131,250 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 5 P Direct
No 4 A Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Convertible Note Acquisiton 2010-12-13 1 $50,000.00 2,761,986 $0.04
Common Stock Convertible Note Acquisiton 2010-04-27 1 $100,000.00 1,357,877 $0.04
Common Stock Convertible Note Acquisiton 2011-08-27 1 $50,000.00 1,279,178 $0.04
Common Stock 5% Convertible Preferred Stock Acquisiton 2012-07-15 31,250 $0.00 1,562,500 $1.50
Common Stock 5% Convertible Preferred Stock Acquisiton 2012-11-04 100,000 $0.00 5,000,000 $1.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,761,986 No 4 A Direct
4,119,863 No 4 A Direct
5,399,041 No 4 A Direct
6,961,541 No 4 A Direct
11,961,541 No 4 A Direct
Footnotes
  1. No specific date set.
  2. Set based upon current price, actual price will be determine on the date of conversion.
  3. N/A